Healthcare Sector Review: Winning and Losing Stocks

Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

  • Amedisys, Inc. (NASDAQ:AMED): The shares closed at $14.99, up $1.33, or 9.74%, on the day. Its market capitalization is $438.59 million. About the company: Amedisys, Inc. is a multi-regional provider of alternate-site health care services. The Company offers home health care nursing, home infusion therapy, and ambulatory surgery centers. Amedisys operates offices within a network of subsidiaries in the southern and southeastern United States.
  • Sucampo Pharmaceuticals (NASDAQ:SCMP): The shares closed at $3.74, up $0.33, or 9.68%, on the day. Its market capitalization is $156.64 million. About the company: Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation.
  • SIGA Technologies, Inc. (NASDAQ:SIGA): The shares closed at $3.16, up $0.23, or 7.85%, on the day. Its market capitalization is $162.15 million. About the company: SIGA Technologies, Inc. explores, develops, and markets products for use in defense against biological warfare agents. The Company’s also offers products such as novel anti-infectives or the prevention and treatment of serious infectious diseases.
  • Simcere Pharmaceutical (NYSE:SCR): The shares closed at $9.15, up $0.6, or 7.02%, on the day. Its market capitalization is $493.22 million. About the company: Simcere Pharmaceutical Group manufactures and supplies branded generic pharmaceuticals to the China market. The Company’s products include antibiotics, anti-cancer medications and anti-stroke medications.
  • Idenix Pharmaceuticals (NASDAQ:IDIX): The shares closed at $5.20, up $0.34, or 7%, on the day. Its market capitalization is $500.00 million. About the company: Idenix Pharmaceuticals Inc. is a biopharmaceutical company that discovers and develops drugs for the treatment of human viral and other infectious diseases. The Company is focusing on the treatment of infections caused by hepatitis B virus, hepatitis C virus, and human immunodeficiency virus (HIV).

Losers (% price change)

  • DaVita Inc. (NYSE:DVA): The shares closed at $62.93, down $6.05, or 8.77%, on the day. Its market capitalization is $5.88 billion. About the company: DaVita, Inc. provides dialysis services in the United States for patients suffering from chronic kidney failure. The Company treats patients through a network of owned and managed dialysis facilities in the continental United States.
  • NuVasive, Inc. (NASDAQ:NUVA): The shares closed at $18.28, down $1.59, or 8%, on the day. Its market capitalization is $729.01 million. About the company: NuVasive, Inc. designs, develops, and markets products for the surgical treatment of spine disorders. The Company’s products include Maximum Access Surgery (NYSE:MAS) and Fusion products.
  • Ariad Pharmaceuticals (NASDAQ:ARIA): The shares closed at $9.07, down $0.78, or 7.87%, on the day. Its market capitalization is $1.20 billion. About the company: ARIAD Pharmaceuticals, Inc. discovers, develops, and commercializes small-molecule drugs to treat aggressive cancers. The Company’s first product candidate is an investigational mTOR inhibitor. ARIAD’s second product candidate is an investigational pan BCR-ABL inhibitor for treatment of blood cancers.
  • Flamel Tech. S.A. (NASDAQ:FLML): The shares closed at $4.22, down $0.36, or 7.75%, on the day. Its market capitalization is $102.85 million. About the company: Flamel Technologies S.A. develops polymer technologies for applications such as drug delivery, biomaterials, and agrochemicals. The Company’s programs include “Micropump” and “Medusa” in drug delivery, and “ColCys” in biomaterial-based medical devices. Flamel builds on its technology platforms to develop other products, such as new materials for opthalmic lens products.
  • Edwards Lifesciences Corp (NYSE:EW): The shares closed at $70.88, down $4.99, or 6.58%, on the day. Its market capitalization is $8.15 billion. About the company: Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company’s products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet